Genetic Engineering & Biotechnology News
March 06, 2019
Rajan Kulkarni, M.D., Ph.D., discusses how circulating tumor cells can be used as a screening tool to supplement other testing methods for an emerging class of cancer therapy candidates.
Jonah Sacha, Ph.D. comments on a new Nature study that outlines the case of a London-based HIV patient who has achieved long-term remission following stem cell transplant.
In response to the Food and Drug Administration’s approval of ketamine for treatment of depression, Erik Turner, M.D. says, “Thank goodness we now have something with a different mechanism of action than previous antidepressants. But I’m skeptical of the hype, because in this world it’s like Lucy holding the football for Charlie Brown: Each time we get our hopes up, the football gets pulled away.”
A second round of the OHSU-UO Collaborative Seed Grant funding program is announced, which develops and builds new collaborations between researchers at OHSU and the University of Oregon.
Research conducted at the Oregon National Primate Research Center determines that mosaic embryos can adapt to their abnormalities and persist in development, resulting in positive IVF outcomes.